Telaprevir Based Antiviral Triple Therapy for HCV Recurrence in Genotype-1 Infected Liver Graft Recipients.

被引：0
|
作者：
Klein, Fritz [1 ]
Neuhaus, Ruth [1 ]
Hofmann, Joerg [2 ]
Guel, Safak [1 ]
Puhl, Gero [1 ]
Neuhaus, Peter [1 ]
Bahra, Marcus [1 ]
机构：
[1] Charite Campus Virchow Univ Med Berlin, Dept Gen Visceral & Transplantat Surg, Berlin, Germany
[2] Charite Campus Mitte Univ Med Berlin, Inst Med Virol, Berlin, Germany
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [1] Successful eradication of genotype 4 HCV with telaprevir-based triple antiviral therapy
    Deneke, M. G.
    Dranoff, J. A.
    Duarte-Rojo, A.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2014, 79 (01): : 64 - 66
  • [2] Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?
    Shiffman, Mitchell L.
    Esteban, Rafael
    LIVER INTERNATIONAL, 2012, 32 : 54 - 60
  • [3] Predictive variables of sustained virological response after early discontinuation of triple therapy with telaprevir for genotype-1 HCV infection
    Acero Fernandez, Doroteo
    Morillas Cunill, Rosa
    Ferri Iglesias, Maria Jose
    Torras Collell, Xavier
    Vergara Gomez, Mercedes
    Zaragoza Velasco, Natividad
    Lopez Nunez, Carmen
    Forne Bardera, Montserrat
    Delgado Gomez, Mercedes
    Barenys Lacha, Merce
    Torres Salinas, Miguel
    Villar Fernandez, Margarita
    Durandez Lazaro, Rosa
    Marino Mendez, Zoe
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (06): : 377 - 384
  • [4] Results of Response Guided Therapy (Rgt) Using Telaprevir Based Triple Therapy in Liver Transplant Recipients With Recurrence of Hepatitis C Virus (HCV) Infection
    Mantry, Parvez S.
    Wu, Chunxia
    Weinstein, Jeffrey S.
    Mubarak, Abdullah
    Nazario, Hector E.
    Mejia, Alejandro
    Cheng, Steve
    Fasola, Carlos
    GASTROENTEROLOGY, 2013, 144 (05) : S1028 - S1028
  • [5] Pegylated Interferon with Ribavirin Therapy and HCV-RNA Titer Impacts Graft Survival on HCV Infected Liver Transplant Recipients.
    Maki, Akira
    Akpinar, Edip
    Martin, Paul
    Schiff, Eugene
    Suzuki, Tetsuya
    Tsunoda, Hajime
    Seung, Shin
    Nishida, Seigou
    Moon, Jang
    Tekin, Akin
    Island, Eddie
    Selvaggi, Gennaro
    Levi, David
    Kato, Tomoaki
    Tzakis, Andreas G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 608 - 608
  • [6] The Effect of IL28 B Genotype on Liver Graft Survival in HCV Infected Recipients Is Independent of Antiviral Treatment
    Allam, S. R.
    Ward, S. C.
    Schiano, T. D.
    Murphy, B.
    Schroppel, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 184 - 184
  • [7] Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non-responders infected with HCV genotype 1
    Akuta, Norio
    Suzuki, Fumitaka
    Seko, Yuya
    Kawamura, Yusuke
    Sezaki, Hitomi
    Suzuki, Yoshiyuki
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Kobayashi, Mariko
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (07) : 1097 - 1105
  • [8] Safety and Efficacy of Telaprevir-Based Triple Therapy to Treat HCV Recurrence Post-Liver Transplantation
    Singh, Tavankit
    Singh, Gurshawn
    Fung, John J.
    Zein, Nizar N.
    Eghtesad, Bijan
    Alkhouri, Naim
    GASTROENTEROLOGY, 2014, 146 (05) : S980 - S980
  • [9] Efficacy of Telaprevir Based Triple Therapy for HCV Recurrence Post-Liver Transplant: Case Reports.
    Patel, V.
    Chapokas, J.
    Mukerji, A. N.
    Black, M.
    Daly, E.
    Karachristos, A.
    Maloo, M.
    Jain, A.
    LIVER TRANSPLANTATION, 2013, 19 : S250 - S250
  • [10] HIGH SVR AFTER TELAPREVIR BASED ANTIVIRAL TRIPLE THERAPY FOR HCV-REINFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION
    Klein, F.
    Eurich, D.
    Neuhaus, R.
    Pratschke, J.
    Bahra, M.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 19 - 19
12345